154 related articles for article (PubMed ID: 33145607)
1. Outcomes of non-metastatic poorly differentiated gastroenteropancreatic neuroendocrine neoplasms treated with surgery: a real-world population-based study.
Abdel-Rahman O; Rahbari N; Reissfelder C; Oweira H
Int J Colorectal Dis; 2021 May; 36(5):941-947. PubMed ID: 33145607
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.
Fang C; Wang W; Zhang Y; Feng X; Sun J; Zeng Y; Chen Y; Li Y; Chen M; Zhou Z; Chen J
Chin J Cancer; 2017 Jun; 36(1):51. PubMed ID: 28637502
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of small-cell versus large-cell gastroenteropancreatic neuroendocrine carcinomas: A population-based study.
Abdel-Rahman O; Fazio N
J Neuroendocrinol; 2021 May; 33(5):e12971. PubMed ID: 33870570
[TBL] [Abstract][Full Text] [Related]
4. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
Zheng M; Li Y; Li T; Zhang L; Zhou L
Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
[TBL] [Abstract][Full Text] [Related]
5. Primary site surgery for elderly patients with distant metastatic pancreatic neuroendocrine tumor: to do or not to do?
Zhang J; Peng CS; Tian YH
Clin Interv Aging; 2019; 14():1419-1432. PubMed ID: 31496669
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
[TBL] [Abstract][Full Text] [Related]
7. [Pathological characteristics and survival analysis of 355 patients with gastroenteropancreatic neuroendocrine neoplasms].
Li Y; Wang YF; Tan BB; Er LM; Zhao Q; Fan LQ; Zhang ZD; Liu Y
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):426-431. PubMed ID: 32482035
[No Abstract] [Full Text] [Related]
8. The impact of surgery and survival prediction in patients with gastroenteropancreatic neuroendocrine tumors: a population-based cohort study.
Wu Z; Wang W; Zhang K; Fan M; Lin R
Int J Surg; 2023 Jun; 109(6):1629-1638. PubMed ID: 37133986
[TBL] [Abstract][Full Text] [Related]
9. Variability of the Ki-67 proliferation index in gastroenteropancreatic neuroendocrine neoplasms - a single-center retrospective study.
Shi H; Zhang Q; Han C; Zhen D; Lin R
BMC Endocr Disord; 2018 Jul; 18(1):51. PubMed ID: 30055596
[TBL] [Abstract][Full Text] [Related]
10. How to Select Patients Affected by Neuroendocrine Neoplasms for Surgery.
Fermi F; Andreasi V; Muffatti F; Crippa S; Tamburrino D; Partelli S; Falconi M
Curr Oncol Rep; 2022 Feb; 24(2):227-239. PubMed ID: 35076884
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population-based study.
Poleé IN; Hermans BCM; van der Zwan JM; Bouwense SAW; Dercksen MW; Eskens FALM; Havekes B; Hofland J; Kerkhofs TMA; Klümpen HJ; Latten-Jansen LM; Speel EM; Verburg FA; Walenkamp AME; Geurts SME; de Vos-Geelen J
Eur J Cancer; 2022 Sep; 172():252-263. PubMed ID: 35803176
[TBL] [Abstract][Full Text] [Related]
12. Does surgery provide a survival advantage in non-disseminated poorly differentiated gastroenteropancreatic neuroendocrine neoplasms?
Thornblade LW; Warner SG; Melstrom L; Ituarte PHG; Chang S; Li D; Fong Y; Singh G
Surgery; 2021 Jun; 169(6):1417-1423. PubMed ID: 33637345
[TBL] [Abstract][Full Text] [Related]
13. Loss of expression and prognosis value of alpha-internexin in gastroenteropancreatic neuroendocrine neoplasm.
Wang Y; Chen Y; Li X; Hu W; Zhang Y; Chen L; Chen M; Chen J
BMC Cancer; 2018 Jun; 18(1):691. PubMed ID: 29940892
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
15. Comparative Clinical Analysis of Gastroenteropancreatic Neuroendocrine Carcinomas with Liver Metastasis and Primary Hepatic Neuroendocrine Carcinomas.
Qiu MJ; Chen YB; Bi NR; Yang SL; He XX; Xiong ZF
Dis Markers; 2018; 2018():9191639. PubMed ID: 30416612
[TBL] [Abstract][Full Text] [Related]
16. A Real-World, Population-Based Study for the Incidence and Outcomes of Neuroendocrine Neoplasms of Unknown Primary.
Abdel-Rahman O
Neuroendocrinology; 2021; 111(9):876-882. PubMed ID: 32980845
[TBL] [Abstract][Full Text] [Related]
17. Microenvironment and tumor inflammatory features improve prognostic prediction in gastro-entero-pancreatic neuroendocrine neoplasms.
Milione M; Miceli R; Barretta F; Pellegrinelli A; Spaggiari P; Tagliabue G; Centonze G; Paolino C; Mangogna A; Kankava K; Pusceddu S; Giacomelli L; Corti A; Cotsoglou C; Mazzaferro V; Sozzi G; de Braud F; Pruneri G; Anichini A
J Pathol Clin Res; 2019 Oct; 5(4):217-226. PubMed ID: 31136102
[TBL] [Abstract][Full Text] [Related]
18. The effect of primary site, functional status and treatment modality on survival in gastroenteropancreatic neuroendocrine neoplasms with synchronous liver metastasis: a US population-based study.
Pu N; Habib JR; Bejjani M; Yin H; Nagai M; Chen J; Kinny-Köster B; Chen Q; Zhang J; Yu J; Wu W; Lou W
Ann Transl Med; 2021 Feb; 9(4):329. PubMed ID: 33708956
[TBL] [Abstract][Full Text] [Related]
19. State of the Art in Endoscopic Therapy for the Management of Gastroenteropancreatic Neuroendocrine Tumors.
Papaefthymiou A; Laskaratos FM; Koffas A; Manolakis A; Gkolfakis P; Coda S; Sodergren M; Suzuki N; Toumpanakis C
Curr Treat Options Oncol; 2022 Jul; 23(7):1014-1034. PubMed ID: 35511346
[TBL] [Abstract][Full Text] [Related]
20. Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms.
Fang C; Wang W; Feng X; Sun J; Zhang Y; Zeng Y; Wang J; Chen H; Cai M; Lin J; Chen M; Chen Y; Li Y; Li S; Chen J; Zhou Z
Br J Cancer; 2017 Nov; 117(10):1544-1550. PubMed ID: 28949958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
